فعالية التكلفة والنجاح السريري لعلاجات القلب للمرضى اليمنيين في الهند (2016-2023)
Cost-Effectiveness and Clinical Success of Cardiac Treatments for Yemeni Patients in India (2016-2023)
الملخص
ملخص البحث:
أمراض القلب والأوعية الدموية هي السبب الرئيسي للوفاة على مستوى العالم.
يهدف البحث إلى تقييم الجدوى الاقتصادية والنتائج السريرية لعلاجات القلب.
المواد وطريقة البحث: راجعنا بشكل رجعي تقارير 1650 مريضاً يمنياً لديهم عيوب قلبية خلقية وأمراض قلب إقفارية، تم علاجهم بين يناير 2016 وديسمبر 2023 في الهند. تم تحليل البيانات المجمعة وحساب المعدلات والمتوسطات والانحراف المعياري، واُستخدم اختبار الـ t، واعتُبر أن قيمة P
Abstract
ABSTRACT
Cardiovascular diseases are the leading cause of mortality globally.
Objective: To evaluate the cost-effectiveness and clinical outcomes of cardiac treatments.
Materials and methods: We retrospectively reviewed the reports of 1650 Yemeni patients with congenital heart defects and ischemic heart diseases treated between January 2016 and December 2023 in India. The collected data were analyzed and estimated rates, means and standard deviations, t-test was used and p-value < 0.05 was considered as statistically significant.
Results: Most of the patients were males with (60.6%) while females were (39.4%). Additionally, most of the patients (57.6%) were of age group > 15 years followed by the age group ≤ 15 years with (42.4%).
The average treatment cost for ischemic heart disease 5800 US Dollar, while the average treatment cost of congenital heart defect was 7200 US Dollar.
Overall, the average treatment cost per patient in US Dollars was approximately 6,500}. The mean success rate for patients with congenital heart defect 89.7% and mean success rate for patients with ischemic heart disease 92.5%.
Conclusion: The high success rates and affordable costs make India an optimal destination for cardiac patients.
Key words: Cost-effectiveness, Cardiac treatment, Yemeni patients, India
.
